Invitation to Apotea’s presentation of the year-end report 2024
Apotea AB (publ) (”Apotea”) will Thursday the 6th of February publish its year-end report Q4 2024. Investors, analysts, media and other interested parties are welcome to join a webcast and presentation of the interim report at 09:30 CET the same day.
The results for the period January – December 2024 will be presented by Pär Svärdson, CEO, Sarah Ahnström, deputy CEO & COO, and Johan Mårild, CFO via a webcast held 6th of February 2025 at 09:30 CET.
Link for webcast participation (no advance notification is necessary): https://apotea.events.inderes.com/q4-report-2024
The presentation will be held in English.
For further information, please contact:
Ingrid Christensson, Investor Relations
Telephone: +46-729 37 95 95
E-mail: ingrid.christensson@apotea.se
About Apotea
Apotea is Sweden’s leading online pharmacy by market share with the goal of becoming the largest pharmacy in Sweden and hence also in the Nordics. With the widest assortment on the market, low prices and quick deliveries, Apotea facilitates everyday life for its three million active customers. In E-barometern’s 2023 customer survey, Apotea was ranked as customers’ favourite e-commerce store for the sixth consecutive year, with almost one in six e-commerce consumers citing Apotea as their favourite. Since 2022, the group also operates in Norway through its Norwegian subsidiary Apotera.